Vitamins

Classification

Fat-soluble(A,D,E,K): absorbed with dietary fat(micelles), STORED(adipose/liver) → genuine toxicity risk with excess. Water-soluble(B-complex, C): generally NOT stored(EXCEPTION: B12, substantial hepatic storage — important exception to pattern), excess renally excreted → lower toxicity risk(not zero — see exceptions below).

Fat-Soluble

Vitamin A: retinal(visual cycle, rhodopsin regeneration — deficiency=night blindness, earliest symptom) + epithelial differentiation(deficiency=xerophthalmia/keratinizing squamous metaplasia, leading preventable childhood blindness cause). Pharmacological doses(isotretinoin, Skin/Mucous Membrane topic) = same RAR mechanism. Toxicity: acute=↑ICP(pseudotumour cerebri); chronic=hepatotoxicity + TERATOGENIC(same RAR-overactivation family of risk as isotretinoin, regardless of drug vs excess-supplement source).

Vitamin D: full detail = Calcium Balance topic(intestinal Ca2+/phosphate absorption, mineralization, deficiency=rickets/osteomalacia, calcitriol=active form bypassing renal activation) — cross-reference, don’t duplicate.

Vitamin E: lipid-soluble antioxidant(membrane protection). Deficiency RARE(except fat-malabsorption states) → haemolytic anaemia+peripheral neuropathy/ataxia. High-dose supplementation: modest ↑bleeding risk(interferes vit-K-dependent factor function) — “just a vitamin” ≠ automatically free of pharmacological interactions.

Vitamin K: full detail = Blood topic(γ-carboxylation of II,VII,IX,X+protein C/S; warfarin blocks its recycling) — cross-reference.

Water-Soluble

Thiamine(B1): cofactor for pyruvate dehydrogenase, α-KG dehydrogenase, transketolase(carb/energy metabolism). Deficiency: beriberi(wet=high-output HF; dry=peripheral neuropathy) + Wernicke-Korsakoff(alcohol context — full detail: Ethyl/Methyl Alcohol topic) — cross-reference the “thiamine BEFORE glucose” practice(glucose metabolism consumes thiamine, can precipitate Wernicke’s if marginal stores).

Niacin(B3): cofactor NAD/NADP redox reactions. Deficiency=pellagra(“3-4 Ds”: dermatitis, diarrhoea, dementia, death). PHARMACOLOGICAL doses: separate lipid-modifying use(↑HDL, ↓TG/LDL — ↓hepatic VLDL synthesis). Limited by near-universal cutaneous FLUSHING(PGD2-mediated vasodilation — ↓by pre-treating with ASPIRIN, blocks PG synthesis) — mechanism-driven, not generic allergic flushing.

Pyridoxine(B6): cofactor amino acid metabolism(transamination, decarboxylation). Deficiency: peripheral neuropathy + SIDEROBLASTIC ANAEMIA(required cofactor for δ-ALA synthase, rate-limiting haem synthesis enzyme). Isoniazid-induced peripheral neuropathy(Antitubercular Drugs) = single most clinically important pyridoxine-deficiency fact in subject(routine co-supplementation given isoniazid’s frequency of use) — cross-reference, don’t re-derive.

B12+Folate: full detail = Blood topic(megaloblastic anaemia; danger of folate-alone masking B12’s neurological progression). KEY LINKING FACT: B12 needed for methylmalonyl-CoA mutase(explains NEUROLOGICAL complications — subacute combined degeneration — unique to B12, NOT folate deficiency) IN ADDITION TO shared methionine synthase step with folate(explains identical megaloblastic anaemia in BOTH deficiencies).

Vitamin C: cofactor for collagen synthesis(proline/lysine hydroxylation, needed for stable triple-helix). Deficiency=scurvy(impaired wound healing, bleeding gums, perifollicular haemorrhages — all traceable to collagen-hydroxylation mechanism). Also antioxidant + enhances non-haem iron absorption(maintains Fe2+ absorbable state) — mechanistic reason for vit-C-with-iron-supplement strategy(Blood topic).

Clinical Relevance

Recurring theme: vitamin deficiency syndromes trace DIRECTLY to a SPECIFIC enzymatic cofactor role, not vague “nutrition” concept — thiamine’s energy-metabolism-enzyme role explains beriberi’s cardiac/neuro picture; pyridoxine’s haem-synthesis role explains sideroblastic anaemia specifically; vitamin C’s collagen-hydroxylation role explains scurvy’s connective-tissue findings. Several most-important facts here(B12/folate, vitamin K, vitamin D, isoniazid-pyridoxine) are GENUINELY SHARED with other topics — hold as ONE integrated understanding, not re-learned twice under different headings.

Classification

Fat-soluble (A, D, E, K) — absorbed with dietary fat via micelle formation, stored in adipose tissue/liver, genuine toxicity risk with excess intake given this storage capacity.

Water-soluble (B-complex, C) — generally not stored to a meaningful degree (with the specific exception of B12, stored substantially in the liver, a genuinely important exception to the general water-soluble-vitamin pattern), excess intake generally excreted renally rather than accumulating, correspondingly lower toxicity risk from oral excess (though not zero, as several specific exceptions below illustrate).

Fat-Soluble Vitamins

Vitamin A (retinol): essential for retinal (visual cycle, specifically rhodopsin regeneration — deficiency classically causing night blindness as the earliest symptom) and for epithelial cell differentiation (deficiency causing xerophthalmia/keratinizing squamous metaplasia of the conjunctiva/cornea, a leading preventable cause of childhood blindness in resource-limited settings). Pharmacological doses (isotretinoin and other retinoids, already covered under Drugs Acting on Skin and Mucous Membrane) exploit the same nuclear retinoic acid receptor mechanism for dermatologic use. Toxicity (hypervitaminosis A): a genuine, dose-related risk given fat-soluble storage — acute toxicity causes raised intracranial pressure (pseudotumour cerebri), and chronic excess causes hepatotoxicity and, critically, is teratogenic (the same mechanistic family of risk already established for isotretinoin, since retinoic acid receptor overactivation during embryogenesis disrupts normal developmental patterning regardless of whether the excess retinoid came from a drug or from excessive vitamin A supplementation itself).

Vitamin D: already covered in mechanistic detail under Drugs for Disorders of Calcium Balance (intestinal calcium/phosphate absorption, bone mineralization, deficiency causing rickets/osteomalacia, calcitriol as the active form bypassing renal activation) — worth cross-referencing rather than duplicating, since the same drug appears in both topics for essentially the same mechanism.

Vitamin E (tocopherol): a lipid-soluble antioxidant, protecting cell membranes from oxidative/free-radical damage — deficiency is genuinely rare (given widespread dietary availability) except in fat-malabsorption states (given its fat-soluble absorption dependence), where it causes a specific haemolytic anaemia and peripheral neuropathy/ataxia picture. High-dose supplementation carries a modestly increased bleeding risk (a specific, examined interaction relevant to patients also on anticoagulants/antiplatelets, thought related to interference with vitamin K-dependent clotting factor function) — a specific, examined point that “just a vitamin” supplements are not automatically free of clinically meaningful pharmacological interactions.

Vitamin K: already covered under Blood (γ-carboxylation of clotting factors II, VII, IX, X and proteins C/S, warfarin’s mechanism of blocking its recycling) — the same cross-referencing point as vitamin D above.

Water-Soluble Vitamins

Thiamine (B1): an essential cofactor for several key metabolic enzymes (pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, transketolase — all central to carbohydrate/energy metabolism) — deficiency causes beriberi (wet — cardiovascular, high-output heart failure; dry — peripheral neuropathy) and, specifically in the context of alcohol use disorder, Wernicke-Korsakoff syndrome (already covered under Ethyl and Methyl Alcohol) — worth cross-referencing that same mechanistic/clinical point rather than re-deriving it here, and reinforcing the specific clinical practice of giving thiamine before glucose in a malnourished/alcoholic patient (glucose metabolism consumes thiamine as a cofactor, and can precipitate/worsen Wernicke’s encephalopathy if marginal thiamine stores are pushed further into deficiency by a glucose load).

Niacin (B3): a cofactor for NAD/NADP-dependent redox reactions across essentially all cellular metabolism — deficiency causes pellagra (classically remembered as the “three/four Ds”: dermatitis, diarrhoea, dementia, and death if untreated). At pharmacological doses, niacin has a genuinely separate, distinct lipid-modifying use — raising HDL cholesterol and lowering triglycerides/LDL more effectively than most other mechanisms available (via reduced hepatic VLDL synthesis and other lipid pathway effects) — though limited by a nearly universal, distinctive adverse effect: cutaneous flushing (a prostaglandin-D2-mediated cutaneous vasodilation, reducible by pre-treatment with aspirin, which blocks the prostaglandin synthesis responsible), a specific, mechanism-driven adverse effect worth recognizing as prostaglandin-mediated rather than a generic allergic-type flushing reaction.

Pyridoxine (B6): a cofactor for numerous amino acid metabolism enzymes (transamination, decarboxylation reactions) — deficiency causes peripheral neuropathy and, specifically, sideroblastic anaemia (pyridoxine is a required cofactor for δ-aminolevulinic acid synthase, the rate-limiting enzyme in haem synthesis) — the mechanistic reason pyridoxine deficiency impairs haem synthesis specifically. Isoniazid-induced peripheral neuropathy (already covered under Antitubercular Drugs) is the single most clinically important, practically relevant pyridoxine-deficiency-related fact in this subject, given how frequently isoniazid is prescribed and how routinely pyridoxine co-supplementation is given specifically to prevent it — worth reinforcing the cross-reference rather than treating it as an isolated new fact here.

Vitamin B12 (cobalamin) and Folate: already covered in detail under Blood (megaloblastic anaemia mechanism, the specific danger of treating B12 deficiency with folate alone masking neurological progression while correcting the anaemia) — the single most important cross-subject-linking fact in the entire vitamin topic, worth restating briefly here rather than assuming the student will independently recall it: B12 is required for methylmalonyl-CoA mutase (deficiency causing the neurological complications — subacute combined degeneration — specific to B12 deficiency, not seen with folate deficiency alone) in addition to the methionine synthase step shared with folate metabolism (the shared step explaining why both deficiencies cause the identical megaloblastic anaemia picture, while B12’s additional, folate-independent role explains the neurological complications unique to B12 deficiency).

Vitamin C (ascorbic acid): a cofactor for collagen synthesis (specifically, hydroxylation of proline and lysine residues, required for stable collagen triple-helix formation) — deficiency causes scurvy (impaired wound healing, bleeding gums, perifollicular haemorrhages, and poor collagen-dependent tissue integrity generally, all directly traceable to the collagen-hydroxylation mechanism). Also functions as a general antioxidant and enhances non-haem (dietary plant-source) iron absorption by maintaining it in the more absorbable ferrous (Fe²⁺) state — the specific mechanistic reason vitamin C co-administration is a standard, examined strategy to improve oral iron supplement absorption already referenced under Blood.

Clinical Relevance

The recurring theme across this topic is that most vitamin deficiency syndromes are directly, mechanistically traceable to a specific enzymatic cofactor role, not a vague “general nutrition” concept — thiamine’s role in central energy metabolism enzymes explains beriberi’s cardiac/neurological picture, pyridoxine’s role in haem synthesis explains sideroblastic anaemia specifically, and vitamin C’s role in collagen hydroxylation explains scurvy’s connective-tissue-specific findings — and several of the most clinically important facts in this topic (B12/folate, vitamin K, vitamin D, isoniazid-pyridoxine) are genuinely shared with other topics already covered in this subject, worth holding as one integrated understanding rather than re-learning the same mechanism twice under two different topic headings.

• B12/folate shared methionine synthase step vs B12-exclusive methylmalonyl-CoA mutase step, explaining shared anaemia but B12-exclusive neurological complications.
• Fat-soluble vs water-soluble vitamin storage/toxicity-risk comparison, with B12 marked as the water-soluble exception.

Short Answers (4)